Skip to search formSkip to main contentSkip to account menu

rivastigmine

Known as: Carbamic acid, ethylmethyl-, 3-(1-(dimethylamino)ethyl)phenyl ester, (S)-, (R-(R*,R*))-2,3-dihydroxybutanedioate (1:1), (S)-N-Ethyl-3-((1-dimethyl-amino)ethyl)-N-methylphenylcarbamate, M-((S)-1-(Dimethylamino)ethyl)phenyl Ethylmethylcarbamate 
A carbamate-derived reversible CHOLINESTERASE INHIBITOR that is selective for the CENTRAL NERVOUS SYSTEM and is used for the treatment of DEMENTIA in… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2007
Highly Cited
2007
RationaleMarked reduction in the cortical nicotinic acetylcholine receptors is observed in the brain of patients suffering from… 
Highly Cited
2004
Highly Cited
2004
Objectives: To predict the treatment response to rivastigmine in patients with Alzheimer’s dementia using neuropsychological and… 
Highly Cited
2004
Highly Cited
2004
Cholinesterase inhibitors (ChEIs) have shown positive symptomatic effects on cognition, activities of daily living, and behavior… 
Review
2002
Review
2002
Objectives: Systematic review of the clinical and cost-effectiveness of donepezil, rivastigmine, and galantamine for people… 
Review
1963
Review
1963
Many studies in laboratory animals have shown that the absorption of fluoride can be influenced by dietary factors, thus…